**AlloVir Announces Chief Executive Officer Transition and Appointment of New CEO**

AlloVir, Inc. (NASDAQ: ALVR) recently disclosed changes in its executive leadership in a Form 8-K filed with the Securities and Exchange Commission dated December 19, 2024. The Board of Directors at AlloVir, Inc. decided on December 19, 2024, that Diana Brainard, MD, would step down from her role as Chief Executive Officer and principal executive […]

Leave a Reply

Your email address will not be published.

Previous post Permian Basin Royalty Trust Announces December Cash Distribution and Excess Cost Position on Waddell Ranch PropertiesOn December 20, 2024, Permian Basin Royalty Trust (NYSE: PBT) declared a cash distribution of $0.021939 per unit to its holders of be
Next post THOR Industries Holds 2024 Annual Shareholders Meeting